BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.
BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refractory... read more
BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update
BioLineRx to Report Third Quarter 2019 Results on November 11, 2019
BioLineRx Q3 2019 Earnings Conference Call
BioLineRx to Deliver Oral Presentation at ESMO
If you would like further information or have questions or comments, please contact:
Tim McCarthy
LifeSci Advisors, LLC
+1-212-915-2564
tim@lifesciadvisors.com
Tsipi Haitovsky
Public Relations
+972-52-598-9892
tsipih@netvision.net.il